Veru (VERU) Competitors

Veru (NASDAQ:VERU) and Nu Skin Enterprises (NYSE:NUS) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, community ranking, dividends, valuation and analyst recommendations.

Does the MarketBeat Community believe in VERU or NUS?

Nu Skin Enterprises received 240 more outperform votes than Veru when rated by MarketBeat users. However, 69.82% of users gave Veru an outperform vote while only 63.81% of users gave Nu Skin Enterprises an outperform vote.

Company	Underperform	Outperform
Veru	Outperform Votes 273 69.82%	Underperform Votes 118 30.18%
Nu Skin Enterprises	Outperform Votes 513 63.81%	Underperform Votes 291 36.19%

Do analysts rate VERU or NUS?

Veru currently has a consensus price target of $4.33, indicating a potential upside of 743.06%. Nu Skin Enterprises has a consensus price target of $6.88, indicating a potential upside of 11.43%. Given Veru's stronger consensus rating and higher possible upside, analysts clearly believe Veru is more favorable than Nu Skin Enterprises.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veru	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Nu Skin Enterprises	0 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Do institutionals & insiders have more ownership in VERU or NUS?

47.2% of Veru shares are owned by institutional investors. Comparatively, 82.8% of Nu Skin Enterprises shares are owned by institutional investors. 14.9% of Veru shares are owned by company insiders. Comparatively, 2.0% of Nu Skin Enterprises shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Which has better valuation & earnings, VERU or NUS?

Veru has higher earnings, but lower revenue than Nu Skin Enterprises. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Veru, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veru	$16.89M	4.46	-$37.80M	-$0.26	-1.98
Nu Skin Enterprises	$1.73B	0.18	-$146.59M	-$2.95	-2.09

Is VERU or NUS more profitable?

Nu Skin Enterprises has a net margin of -8.46% compared to Veru's net margin of -223.85%. Nu Skin Enterprises' return on equity of 5.86% beat Veru's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veru	-223.85%	-112.75%	-67.54%
Nu Skin Enterprises	-8.46%	5.86%	2.62%

Does the media prefer VERU or NUS?

In the previous week, Veru had 1 more articles in the media than Nu Skin Enterprises. MarketBeat recorded 2 mentions for Veru and 1 mentions for Nu Skin Enterprises. Veru's average media sentiment score of 1.19 beat Nu Skin Enterprises' score of 1.08 indicating that Veru is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veru	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nu Skin Enterprises	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more volatility & risk, VERU or NUS?

Veru has a beta of -0.69, meaning that its stock price is 169% less volatile than the S&P 500. Comparatively, Nu Skin Enterprises has a beta of 1.1, meaning that its stock price is 10% more volatile than the S&P 500.

Summary

Veru beats Nu Skin Enterprises on 11 of the 18 factors compared between the two stocks.